Described herein are pharmaceutical packaging methods which avoid oxidative degradation of morphine, hydromorphone, promethazine along with other oxygen-delicate drugs, these units like a syringe with the oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with pretty minimal permeability to oxygen and comprises ethylen